access
The broken promise of affordable insulin
Mariam Zuhaib / AP
In February 2022, Senate Majority Leader Chuck Schumer stood alongside constituents in Buffalo, N.Y. and promised to hold a vote to cap costs for insulin at $35 per month for people with all types of insurance. Following those remarks, he promised again to hold a vote to cap insulin costs the next month. He repeated the call over that summer. He continued to call for a vote in March 2023. He said the legislation was a "high priority" last July. And most recently, he called for a vote in a letter to senators on April 5.
Some people have stopped believing him. "It just feels really really gross to be used as a political prop for campaigning and then have nothing be done to actually substantively help us," patient advocate Laura Marston told STAT's Rachel Cohrs Zhang.
Why hasn't a vote been put on the Senate calendar? Read more from Rachel on Schumer's oft-repeated promise, the progress that has been made on insulin affordability, and what can realistically happen as this election year continues.
first opinion
Autism doesn't discriminate. Autism research shouldn't either
Last year, the Centers for Disease Control and Prevention reported that the prevalence of autism is evening out across racial and ethnic groups. Many believe that the shift is due to more accurate diagnoses after decades of overlooking children who weren't white. Among 8-year-olds in particular, autism was more commonly identified among Black, Hispanic and Asian American/Pacific Islander children than among their white counterparts for the first time ever.
But research shows that families of color face social and systemic barriers as they navigate the complex world of autism diagnosis and access to services. In a First Opinion, researcher and Boston Children's Hospital pediatrics chief Wendy Chung explains the bias and racism that exist in the field, and how to combat it. Read more.
research
Childhood trauma could impair muscle function later in life, study suggests
Traumatic childhood experiences could impair muscle function as people age, according to a new study published yesterday in Science Advances.
Researchers examined skeletal muscle tissue samples from over 800 participants over the age of 70 to measure two important parts of muscular function: the production of adenosine triphosphate, or ATP, a compound that provides energy to fuel cell function, and oxidative phosphorylation, a process that helps produce ATP. The authors also had participants fill out questionnaires about family drug and alcohol use, physical abuse, and more.
People who reported more adverse childhood events had worse production of ATP than people who experienced fewer or none. This negative correlation remained even after controlling for factors like age, gender, body mass index, and physical activity. The study authors believe these results provide preliminary evidence for how trauma can affect the body. However, they add that more research is needed, as this paper relied on participants' memories.
No comments